C. Pereira

Evading P‐glycoprotein mediated‐efflux chemoresistance using Solid Lipid Nanoparticles

M. Videira, L. Gouveia, M. Cavaco, 2017, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

MET-Oncogenic and JAK2-Inactivating Alterations Are Independent Factors That Affect Regulation of PD-L1 Expression in Lung Cancer

E. Brambilla, E. Pros, M. Sanchez-Cespedes, 2018, Clinical Cancer Research.

Self-assembly PEGylation assists SLN-paclitaxel delivery inducing cancer cell apoptosis upon internalization.

S. Schwartz, A. Arranja, M. Videira, 2016, International journal of pharmaceutics.

Phase II trial of cisplatin and alpha-interferon in advanced malignant melanoma.

J. Doroshow, L. Leong, S. Akman, 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Genomic Profiling of Patient-Derived Xenografts for Lung Cancer Identifies B2M Inactivation Impairing Immunorecognition.

J. Yokota, D. Pisano, E. Felip, 2017, Clinical cancer research : an official journal of the American Association for Cancer Research.

Genomic Profiling of Patient-Derived Xenografts for Lung Cancer Identifies B2M Inactivation Impairing Immunorecognition

J. Yokota, D. Pisano, E. Felip, 2017, Clinical Cancer Research.

Looking out for cancer stem cells' properties: the value-driving role of CD44 for personalized medicines.

S. Doktorovová, M. Videira, Rita Mateus, 2015, Current cancer drug targets.

MET-Oncogenic and JAK2-Inactivating Alterations Are Independent Factors That Affect Regulation of PD-L1 Expression in Lung Cancer

E. Brambilla, E. Pros, M. Sanchez-Cespedes, 2018, Clinical Cancer Research.